Journal of Experimental & Clinical Cancer Research Citation Rate 2026

ISSN 1756-9966 BioMed Central GB

Q1 Quartile Open Access Top Tier

About Journal of Experimental & Clinical Cancer Research
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Journal of Experimental & Clinical Cancer Research (JECCR) is a peer-reviewed academic journal covering Cancer Cells and Metastasis and Cancer, Hypoxia, and Metabolism, published by BioMed Central in GB, catalogued under ISSN 1756-9966. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 10.31 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2919 USD.

Journal of Experimental & Clinical Cancer Research Citation Rate 2026 — In Context

Journal of Experimental & Clinical Cancer Research has a 2025 2-Year Citation Rate (OpenAlex) of 10.31, placing it in the Q1 quartile within the Cancer Cells and Metastasis research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Journal of Experimental & Clinical Cancer Research makes all articles freely available to readers for an Article Processing Charge of approximately $2919 USD.

Researchers looking to publish in Journal of Experimental & Clinical Cancer Research should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal of Experimental & Clinical Cancer Research against similar journals in the field, use our journal comparison tool.

Submission Tips for Journal of Experimental & Clinical …
  • Budget $2919 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Journal of Experimental … Compares
Citation Rate vs Field Avg
+354%
Field avg: 2.27
APC vs Field Avg
-5%
Field avg: $3082

Compared against 7 journals in the same research areas.

ISSN (Print) 1756-9966
Publisher BioMed Central
Country United Kingdom
APC / Cost $2919 USD
In-depth profile & metrics

Journal of Experimental & Clinical Cancer Research is published by BioMed Central and based in United Kingdom. It publishes open access with an article-processing charge of USD 2919.

In our subject taxonomy, Journal of Experimental & Clinical Cancer Research is classified under Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research and Circular RNAs in diseases.

Journal of Experimental & Clinical Cancer Research is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 10.308.

Research Areas
Links
Frequently Asked Questions about Journal of Experimental & Clinical …

Journal of Experimental & Clinical Cancer Research does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 10.308 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Journal of Experimental & Clinical Cancer Research is an open access journal.

The Article Processing Charge (APC) for Journal of Experimental & Clinical Cancer Research is $2919 USD.

Journal of Experimental & Clinical Cancer Research is published by BioMed Central.

Journal of Experimental & Clinical Cancer Research shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Journal of Experimental & Clinical Cancer Research is 1756-9966.

Journal of Experimental & Clinical Cancer Research sits in the Q1 quartile based on its latest impact factor of 10.31, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
10.308
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 10.308 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Journal of Experimental & Cli… against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S33781645

Get weekly updates for Cancer Cells and Metastasis journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google